SCHEMBL1785217

SCHEMBL1785217

NC(=O)c1cc(C2CC2)ccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ ACMSD Q8TDX5 2/20 0.44
▸ SLC6A2 P23975 4/20 0.43
▸ SLC6A4 P31645 4/20 0.43
▸ SLC6A3 Q01959 4/20 0.43
▸ P2RX7 Q99572 1/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ DHODH Q02127 2/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA3 P07451 1/20 0.39
▸ CA4 P22748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1787918 0.93 ACMSD (0.53) NPSR1ALDH1A1LMNAMAPTHPGD
SCHEMBL3384439 0.89 P2RX7 (0.55) NPSR1ALDH1A1LMNAMAPTHPGD
SCHEMBL18296100 0.86 KMT2A (0.47) NPSR1ALDH1A1MAPTHPGDHTT
SCHEMBL1786184 0.84 ACMSD (0.57) ALDH1A1LMNAMAPTACMSDSLC6A2
SCHEMBL21434705 0.81 ALDH1A1 (0.60) ALDH1A1LMNAMAPTHPGDACMSD
SCHEMBL3381905 0.80 DRD2 (0.56) KMT2A
SCHEMBL28193482 0.79 ACMSD (0.44) ACMSDDHODHCYP2C9
SCHEMBL18668155 0.78 MEN1 (0.50) NPSR1ALDH1A1LMNAMAPTHPGD
SCHEMBL16959401 0.78 ACMSD (0.39) ACMSDSLC6A2SLC6A4SLC6A3P2RX7
SCHEMBL1786025 0.78 NPSR1 (0.39) NPSR1ALDH1A1LMNAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130203730-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2013-08-08 — — US disclosed
EP-2607357-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS Astrazeneca AB (SE) 2013-06-26 — — EP disclosed
US-20120115845-A1 THERAPEUTIC AGENTS ALLEN JACK MCQUEEN (GB) 2012-05-10 — — US disclosed
US-20110124621-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2011-05-26 — — US disclosed
EP-2205576-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS AstraZeneca AB (SE) 2010-07-14 — — EP disclosed
US-20090186870-A1 Therapeutic Agents - 802 ASTRAZENECA AB (SE) 2009-07-23 — — US disclosed
WO-2009047558-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2009-04-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130203730-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS GPR119, GHSR, GLP1R NPSR1 80/4885ALDH1A1 2084/4885LMNA 4721/4885
US-20120115845-A1 THERAPEUTIC AGENTS GPR119, MC2R, MC4R NPSR1 142/4885ALDH1A1 650/4885LMNA 4327/4885
US-20090186870-A1 Therapeutic Agents - 802 GPR119, SLC5A2, MC2R NPSR1 139/4885ALDH1A1 918/4885LMNA 4113/4885
US-20110124621-A1 BENZOTHIAZOLES AS GHRELIN RECEPTOR MODULATORS GPR119, GHSR, GLP1R NPSR1 80/4885ALDH1A1 2084/4885LMNA 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback